Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 11 | 1.470 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2025 | 18 | 1.470 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2025 | 23 | 1.300 |
Why?
|
| Lysosomes | 3 | 2025 | 21 | 1.280 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 195 | 1.180 |
Why?
|
| Signal Transduction | 3 | 2025 | 225 | 0.970 |
Why?
|
| Coronary Circulation | 1 | 2024 | 6 | 0.910 |
Why?
|
| Microcirculation | 1 | 2024 | 7 | 0.910 |
Why?
|
| Hypercholesterolemia | 1 | 2024 | 13 | 0.900 |
Why?
|
| Coronary Vessels | 1 | 2024 | 25 | 0.890 |
Why?
|
| Cell Movement | 3 | 2025 | 64 | 0.810 |
Why?
|
| Cell Proliferation | 3 | 2025 | 120 | 0.800 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 242 | 0.790 |
Why?
|
| Piperidines | 2 | 2025 | 17 | 0.690 |
Why?
|
| Diet, High-Fat | 2 | 2024 | 35 | 0.670 |
Why?
|
| Neointima | 1 | 2019 | 8 | 0.630 |
Why?
|
| Cells, Cultured | 5 | 2025 | 134 | 0.610 |
Why?
|
| Mice | 6 | 2025 | 719 | 0.550 |
Why?
|
| Animals | 7 | 2025 | 1817 | 0.470 |
Why?
|
| Endothelial Cells | 2 | 2024 | 48 | 0.380 |
Why?
|
| Male | 4 | 2024 | 2765 | 0.320 |
Why?
|
| Autophagy | 3 | 2025 | 31 | 0.320 |
Why?
|
| Mice, Knockout | 3 | 2025 | 143 | 0.260 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2025 | 13 | 0.230 |
Why?
|
| Ezetimibe | 1 | 2024 | 3 | 0.230 |
Why?
|
| Acid Ceramidase | 1 | 2024 | 6 | 0.230 |
Why?
|
| Anticholesteremic Agents | 1 | 2024 | 6 | 0.230 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 9 | 0.230 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 14 | 0.230 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 11 | 0.230 |
Why?
|
| Homeostasis | 1 | 2024 | 30 | 0.220 |
Why?
|
| Atherosclerosis | 1 | 2025 | 16 | 0.220 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 35 | 0.220 |
Why?
|
| Cell Differentiation | 1 | 2025 | 75 | 0.220 |
Why?
|
| Liver | 1 | 2024 | 51 | 0.220 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2024 | 2 | 0.220 |
Why?
|
| Hypertension | 1 | 2024 | 61 | 0.200 |
Why?
|
| Simvastatin | 1 | 2020 | 5 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 9 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 20 | 0.160 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2020 | 39 | 0.160 |
Why?
|
| Inflammasomes | 1 | 2020 | 39 | 0.150 |
Why?
|
| Humans | 4 | 2025 | 5476 | 0.080 |
Why?
|
| Calcineurin | 1 | 2025 | 11 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2024 | 13 | 0.060 |
Why?
|
| Macrophages | 1 | 2025 | 29 | 0.060 |
Why?
|
| Support Vector Machine | 1 | 2024 | 3 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2024 | 10 | 0.050 |
Why?
|
| Proteinuria | 1 | 2024 | 10 | 0.050 |
Why?
|
| Machine Learning | 1 | 2024 | 39 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2020 | 6 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 11 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2020 | 15 | 0.040 |
Why?
|
| Cell Survival | 1 | 2020 | 57 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 21 | 0.040 |
Why?
|
| Adult | 1 | 2024 | 1683 | 0.030 |
Why?
|